Pinnacle Hill

About Pinnacle Hill

Pinnacle Hill is a collaborative venture between UNC Chapel Hill and Deerfield Management, focusing on advancing promising new drug research across a wide range of therapeutic areas. The company operates in the pharmaceutical and biotechnology market, specifically targeting early-stage drug development projects. Pinnacle Hill's business model involves selecting and funding drug research projects that are approved by a joint steering committee from both UNC Chapel Hill and Deerfield. Deerfield Management commits up to $65 million in targeted funding and provides significant drug development expertise to support investigational new drug (IND) enabling studies. This partnership aims to accelerate the development of innovative therapies by leveraging the academic research capabilities of UNC Chapel Hill and the financial and operational expertise of Deerfield Management.